Sarkar Surojit, Kalia Vandana, Montelaro Ronald C
Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15261, USA.
Cryobiology. 2003 Aug;47(1):44-58. doi: 10.1016/s0011-2240(03)00068-3.
Cryopreservation of peripheral blood mononuclear cells (PBMC) from animal model studies and clinical trials is utilized as a primary method for long-term storage of PBMC for future in vitro and in vivo applications. The objective of this study was to define the mechanistic pathways involved in cryopreservation-induced apoptosis of CD4+ T-cells in PBMC, and to evaluate a cytokine treatment of the cryopreserved samples to rescue apoptosis for the potential future use of the cryopreserved PBMC. Using cryopreserved PBMC samples isolated from naïve and Simian immunodeficiency virus (SIV)-infected rhesus macaques as a model, frozen PBMC showed significantly increased levels of apoptosis-induced CD4+ T-cell death compared to fresh PBMC over a 5-day culture period as detected by Annexin V/PI and trypan blue staining. Mechanistic studies using a broad-spectrum caspase inhibitor z-VAD demonstrated a crucial involvement of caspases in cryopreservation-induced apoptosis of CD4+ T-cells. Furthermore, the ability of z-VAD to inhibit both mitochondrial membrane perturbation and apoptotic cell death implicated the involvement of caspase-mediated mitochondrial membrane damage in cryopreservation-induced apoptosis of CD4+ T-cells. Due to their known properties to promote T-cell survival and inhibit apoptosis, we evaluated the ability of IL-2, IL-4, and IL-7 combination cytokine treatment of the cryopreserved cells to rescue apoptosis of the CD4+ T-cells. The cytokine treatment resulted in a significant inhibition (p<0.01) of apoptosis-induced cell death and rescued CD4+ T-cell survival (p<0.01) in the cryopreserved cells. Efficient rescue of cryopreserved CD4+ T-cells has clinical significance in immune function analysis of longitudinal samples and in various long-term protocols requiring cryopreservation, including bone marrow and stem cell transplantation.
在动物模型研究和临床试验中,外周血单个核细胞(PBMC)的冷冻保存被用作PBMC长期储存的主要方法,以供未来体外和体内应用。本研究的目的是确定PBMC中冷冻保存诱导CD4+ T细胞凋亡所涉及的机制途径,并评估对冷冻保存样本进行细胞因子处理以挽救凋亡,从而为未来冷冻保存的PBMC的潜在应用提供支持。以从未感染和感染猿猴免疫缺陷病毒(SIV)的恒河猴中分离出的冷冻保存PBMC样本为模型,通过Annexin V/PI和台盼蓝染色检测发现,与新鲜PBMC相比,在5天的培养期内,冷冻PBMC诱导的CD4+ T细胞凋亡水平显著增加。使用广谱半胱天冬酶抑制剂z-VAD进行的机制研究表明,半胱天冬酶在冷冻保存诱导的CD4+ T细胞凋亡中起关键作用。此外,z-VAD抑制线粒体膜扰动和凋亡细胞死亡的能力表明,半胱天冬酶介导的线粒体膜损伤参与了冷冻保存诱导的CD4+ T细胞凋亡。由于白细胞介素-2(IL-2)、白细胞介素-4(IL-4)和白细胞介素-7(IL-7)已知具有促进T细胞存活和抑制凋亡的特性,我们评估了用这三种细胞因子联合处理冷冻保存细胞以挽救CD4+ T细胞凋亡的能力。细胞因子处理导致冷冻保存细胞中凋亡诱导的细胞死亡显著受到抑制(p<0.01),并挽救了CD4+ T细胞的存活(p<0.01)。有效挽救冷冻保存的CD4+ T细胞在纵向样本的免疫功能分析以及包括骨髓和干细胞移植在内的各种需要冷冻保存的长期方案中具有临床意义。